[Updated] UK SACT Board: Good Practice Guidance for Immuno-Oncology Medicines

UK SACT Board

 

Good Practice Guidance for Immuno-Oncology Medicines – May 2024

The UK SACT Board’s Good Practice Guidance for Immuno-Oncology Medicines has been updated.

This guideline is designed to give a practical framework for the safe introduction and ongoing use of immunotherapy in existing Systemic Anti-Cancer Therapy (SACT) services.

This guideline is available on the UK SACT Board publication page: https://www.uksactboard.org/publications

Latest News

By BOPA Committee on 11th September 2024

BCS/BCOS/UCLH Cancer Academy Cardio-Oncology Course, 11 November 2024, Royal College of Physicians, London

This joint British Cardiovascular Society, British Cardio-Oncology Society and University College London Hospitals Cancer Academy course provides an update in contemporary cardio-oncology practice and will cover recent updates in cardio-oncology.…

Read article
By BOPA Research Committee on 11th September 2024

Treatment delays and new evidence

Dear BOPA members We are delighted to share two studies that you may be interested in for your practices.  The studies outline the impact of treatment delays (i.e. Delays in…

Read article
By BOPA Research Committee on 9th September 2024

BOPA member publication on the impact of inter-cycle treatment delays on mortality in early-stage breast cancer

We would like to share a recent BOPA member publication Pinkie Chambers et al. The impact of inter-cycle treatment delays on 5-year all-cause mortality in early-stage breast cancer: A retrospective…

Read article
By BOPA Research Committee on 9th September 2024

My Research Webinar: Understanding global participation in gynae-oncology RCTs: a systematic review approach

Wednesday 25th September 2024 13:00 GMT   Register for the Session HERE: https://www.bopa.org.uk/webinarsignupform/   We would like to invite you to join our  ‘My Research’ sessions. These sessions are delivered…

Read article